Literature DB >> 23125303

Paediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia.

Gautamn Sarwal1, Ahmad Al-Sarraf, Jiri Frohlich.   

Abstract

An 11-year-old girl presented with palmar and tuberoeruptive xanthomas, and elevated triglycerides and total cholesterol levels. She had an apolipoprotein E2/E2 genotype. A diagnosis of type III dyslipidaemia was made and the patient started on niacin, fenofibrate and salmon oil. At age 18, her lipid levels were well controlled with fenofibrate once weekly. At age 21, the fenofibrate was discontinued and her lipid profile has been normal for the last 4 years. This case history may be consistent with a transient dyslipidaemia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125303      PMCID: PMC4544214          DOI: 10.1136/bcr-2012-007579

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Acquired lipoprotein lipase deficiency associated with chronic urticaria. A new etiology for type I hyperlipoproteinemia.

Authors:  A L García-Otín; F Civeira; J Peinado-Onsurbe; C Gonzalvo; M Llobera; M Pocoví
Journal:  Eur J Endocrinol       Date:  1999-11       Impact factor: 6.664

Review 2.  Antibody interference in thyroid assays: a potential for clinical misinformation.

Authors:  N Després; A M Grant
Journal:  Clin Chem       Date:  1998-03       Impact factor: 8.327

3.  Transient dyslipidemia mimicking the plasma lipid profile of Tangier disease in a diabetic patient with gram negative sepsis.

Authors:  Carlos Palacio; Irene Alexandraki; Roger L Bertholf; Arshag D Mooradian
Journal:  Ann Clin Lab Sci       Date:  2011       Impact factor: 1.256

Review 4.  Aripiprazole in schizophrenia and schizoaffective disorder: A review.

Authors:  Emmanuel Stip; Valérie Tourjman
Journal:  Clin Ther       Date:  2010       Impact factor: 3.393

5.  Case series of type III hyperlipoproteinemia in children.

Authors:  Michelle Fung; John Hill; Donald Cook; Jiri Frohlich
Journal:  BMJ Case Rep       Date:  2011-06-09

6.  Hypertriglyceridemia as a cardiovascular risk factor.

Authors:  M A Austin; J E Hokanson; K L Edwards
Journal:  Am J Cardiol       Date:  1998-02-26       Impact factor: 2.778

7.  Familial dysbetalipoproteinemia: a potentially fatal disorder.

Authors:  Arfan Ul Bari; Rizwan Hashim; Simeen Ber Rahman; Majid Hussain
Journal:  J Coll Physicians Surg Pak       Date:  2008-08       Impact factor: 0.711

8.  Transient, severe hyperlipidemia in patients with acute lymphoblastic leukemia treated with prednisone and asparaginase.

Authors:  P G Steinherz
Journal:  Cancer       Date:  1994-12-15       Impact factor: 6.860

9.  Dysbetalipoproteinaemia--clinical and pathophysiological features.

Authors:  D J Blom; P Byrnes; S Jones; A D Marais
Journal:  S Afr Med J       Date:  2002-11

10.  Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study.

Authors:  Supna Sandhu; Ahmad Al-Sarraf; Catalin Taraboanta; Jiri Frohlich; Gordon A Francis
Journal:  Lipids Health Dis       Date:  2011-09-11       Impact factor: 3.876

View more
  1 in total

1.  Targeting PPARα in the rat valproic acid model of autism: focus on social motivational impairment and sex-related differences.

Authors:  Simona Scheggi; Francesca Guzzi; Giulia Braccagni; Maria Graziella De Montis; Marco Parenti; Carla Gambarana
Journal:  Mol Autism       Date:  2020-07-27       Impact factor: 7.509

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.